Iterum Therapeutics plc - Ordinary Share (ITRM) Social Stream



Iterum Therapeutics plc - Ordinary Share (ITRM): $1.47

0.04 (+3.01%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

ITERUM THERAPEUTICS PLC (ITRM) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ITERUM THERAPEUTICS PLC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
NA 1 $NA $NA $NA $2.01 NA%

Price Target Last Issued NA NA, NA

The Trend in the Analyst Price Target


Over the past 14 months, ITRM's average price target has gone down $2.5.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

ITRM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The Trend in the Broker Recommendations


ITRM's average broker recommendation rating worsened by 0.33 over the prior 122 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, ITERUM THERAPEUTICS PLC's number of analysts covering the stock is greater than just about none of of them.
  • ITRM has a lower variance in analysts' estimates than almost 100% of stocks in the small market cap category.
  • ITRM has a higher average analyst price target than just about none of of stocks in the small market cap category.
  • In the context of stocks in the small market cap category, ITERUM THERAPEUTICS PLC's upside potential (average analyst target price relative to current price) is higher than just about none of of them.

In the Pharmaceutical Products industry, SLGL, COGT, and UBX are the three stocks most similar to ITERUM THERAPEUTICS PLC regarding the price target and analyst recommendation information presented here.

What is the outlook for ITRM? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!